New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies
National Institutes of Health
This opportunity closed June 17, 2026. 4 similar opportunities are open right now.
Similar opportunities open now
- Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)OpenNational Institutes of HealthCloses in 81 days
- Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 64 days
- Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)OpenNational Institutes of HealthCloses in 71 daysUp to $300K
- PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)OpenNational Institutes of HealthCloses in 81 days
About this archived opportunity
The purpose of this funding opportunity is to support research addressing barriers that limit progress toward more effective open- and closed-loop diabetes control systems. This may include research that addresses: 1) innovation of sensing relevant analytes/physiologic signals; 2) novel formulation and delivery of hormones; 3) artificial intelligence (AI)/machine learning (ML)-driven tools/algorithms; and 4) digital twin modeling to augment decision support and automated control systems with the goal of improving glycemic control, reducing burden of care, and enhancing quality of life of people with T1D].This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks
Historical details
- Status
- Closed
- Deadline
- June 17, 2026
- First captured
- October 23, 2025
- Award
- $500,000
- Publisher reference
- 359200
Eligibility: Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
This opportunity has closed
New Generation of Glucose Control Technologies Incorporating AI/ML Tools/Strategies
by National Institutes of Health
Get notified when similar opportunities open
We'll save this search and email you when new generation, glucose, control opportunities are posted. Free.
Related opportunities
- Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)National Institutes of HealthCloses in 81 days
- Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)National Institutes of HealthCloses in 64 days
- Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)National Institutes of HealthCloses in 71 daysUp to $300K